Jobs
岗位职责:
- 主导环境监测相关工作,包括环境监测策略、风险评估及管理规程或操作规程的制定,组织洁净区、公用系统(水系统、空调系统、压缩空气等)的日常监控;
- 主导环境数据的收集、统计分析及回顾,持续提升洁净区环境监测水平;
- 组织微生物相关方法的建立以及验证工作,组织和负责微生物小组的项目检测工作 ,包括原液和制剂的放行,中间品的控制,原辅料和包材的入厂检测;
- 主导菌种鉴定库以及环境菌株库的建立;
- 组织和参与微生物污染事件的调查与分析;
- 负责审核部门相关文件、记录、检验数据等;
- 领导安排的其它工作。
任职要求:
- 本科及以上学历,生物学、医药等相关专业;
- 至少5年及以上微生物分析或检测经验,3年及以上的环境监测经历,至少两年以上QC管理工作经验;有无菌制剂产品相关经历的,有消毒剂效力验证的,优先考虑;
- 熟悉中国药典、GMP、USP等国内外微生物相关的,包括检测方法、环境管理等法规;
- 有丰富的应对官方、客户等审计经验,并制定有效CAPA;有污染控制策略制定的经验,优先考虑;
- 了解生物大分子产品生产规律;熟悉检测方法及其原理,了解微生物的生长特性,能指导相关部门进行微生物管控;
- 有特种设备作业证(压力容器);
- 熟悉无菌隔离器、灭菌柜等微生物检测相关设备操作;
- 具备良好的沟通协调及团队协作能力,有高度责任心和强烈的服务意识。具有项目管理能力;
- 良好的英语听说写能力。
Total Views
0
Apply Clicks
0
Weekly mock applicants
0
Bookmarks
0
Similar jobs
About BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
Employees
Mainz that develops immunotherapies
Headquarters
$21.7B
Valuation
Reviews
4.0
10 reviews
Work-life balance
2.5
Compensation
3.8
Culture
4.2
Career
3.5
Management
3.2
75%
Recommend to a friend
Pros
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
Cons
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
Salary Ranges
70 data points
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0 reports
$53,767
total per year
Base
$21,507
Stock
$26,884
Bonus
$5,377
$37,637
$69,897
Interview experience
1 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Interview process
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
Common questions
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
News & Buzz
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
1d ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
6d ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
6d ago



